HMG CoA redüktaz inhibitörlerinin plazma ubikinon, ATP düzeyi ve total antioksidan kapasite üzerine etkilerinin incelenmesi
dc.contributor.advisor | Önvural, Banu | |
dc.contributor.author | Altekin, Emel | |
dc.date.accessioned | 2021-05-05T09:15:30Z | |
dc.date.available | 2021-05-05T09:15:30Z | |
dc.date.submitted | 1999 | |
dc.date.issued | 2021-04-20 | |
dc.identifier.uri | https://acikbilim.yok.gov.tr/handle/20.500.12812/581190 | |
dc.language | Turkish | |
dc.language.iso | tr | |
dc.rights | info:eu-repo/semantics/embargoedAccess | |
dc.rights | Attribution 4.0 United States | tr_TR |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Biyokimya | tr_TR |
dc.subject | Biochemistry | en_US |
dc.title | HMG CoA redüktaz inhibitörlerinin plazma ubikinon, ATP düzeyi ve total antioksidan kapasite üzerine etkilerinin incelenmesi | |
dc.title.alternative | The Effects of HMG CoA reductase inhibitors on plasma ubiquinone, ATP concentrations and total antioksidant status | |
dc.type | doctoralThesis | |
dc.date.updated | 2021-04-20 | |
dc.contributor.department | Biyokimya Ana Bilim Dalı | |
dc.subject.ytm | Anticholesteremic agents | |
dc.subject.ytm | Ubiquinone | |
dc.subject.ytm | Adenosine triphosphate | |
dc.subject.ytm | Antioxidants | |
dc.subject.ytm | Cholesterol | |
dc.subject.ytm | Cholesterol-LDL | |
dc.subject.ytm | Hypercholesterolemia | |
dc.identifier.yokid | 88977 | |
dc.publisher.institute | Tıp Fakültesi | |
dc.publisher.university | DOKUZ EYLÜL ÜNİVERSİTESİ | |
dc.type.sub | medicineThesis | |
dc.identifier.thesisid | 88977 | |
dc.description.pages | 91 | |
dc.publisher.discipline | Diğer |